retatrutide diabetes type 1 Retatrutide: The first-in-class investigational triple receptor agonist redefining 2 therapy There's a new drug in

If approved, your provider will write a legitimate prescription that must be filled at a registered, state-licensed pharmacy

IBX will continue to provide coverage for GLP-1 drugs prescribed to your patients (our members) for FDA-approved medical conditions and indications, including type 2 diabetes and cardiovascular disease, with prior authorization

If youre currently on semaglutide and are unsure why the medication isnt having the desired effect, wed recommend speaking with your GP or NHS weight management service if youre based in the UK, or consult your local healthcare provider if outside the UK

Access is still an issue for these effective medications. Clare Thompson, MD, a general practitioner who leads weight management services at the Cadogan Clinic in London, agrees

If you need to lose 15-20% of your body weight, semaglutide may be entirely sufficient